SOAT1 and psoriasis: In psoriasis, another research found that subcutaneous administration of SOD-MSCs (UC-MSCs) in mice (2 × 106 cells) can ameliorate the symptoms of skin lesion by regulating the inflammatory pathways including toll-like receptor-7, nuclear factor-kappa B(NFκB), p38 mitogen-activated kinase (MAPK), and JAK-STAT pathways (71) (Figure 2).